[Abstract]2025 May;31(5):111
In those same studies, a subset of patients around 10% to 15% lost less than 5% of their body weight, the threshold often used to define meaningful weight loss
For anyone who feels overwhelmed by injections or cant afford real medications, the idea of a patch can feel less like advertising and more like a lifeline
Are you keen to uncover the secret to increasing your glutathione levels, a powerful antioxidant that plays a pivotal role in maintaining your well-being
Peptides, a class of compounds increasingly marketed as wellness treatments, have exploded in popularity in recent years, moving from niche bodybuilding and biohacking circles to now being promoted for everything from weight loss to longevity
Global regulatory frameworksespecially the ICH S1 series guidelinesrequire structured carcinogenicity assessment: ICH S1A/S1B/S1C define when lifetime rodent studies are required Emphasis on hazard identification rather than direct human prediction Adoption of Weight-of-Evidence (WoE) approaches in ICH S1B(R1) The updated S1B(R1) guideline specifically encourages: Integration of mechanistic, exposure, and translational data Reduced reliance on 2-year rodent bioassays when justified Greater emphasis on human relevance and multi-factor evidence This shift reflects a broader regulatory evolution toward mechanism-based safety assessment rather than purely animal-driven hazard signals